Skip to main content
. 2024 Oct 26;74(1):e332804. doi: 10.1136/gutjnl-2024-332804

Figure 2. Proportion (%) of bismuth quadruple therapy (over all Helicobacter pylori treatments) by European country. Countries in grey did not participate in the registry.

Figure 2